Active Ingredient(s):Emapalumab-lzsg FDA Approved: * November 20, 2018 Pharm Company: *NOVIMMUNE S.A. Category:Genetic Disorders
Emapalumab, sold under the brand name Gamifant, is an anti-interferon-gamma (IFNγ) antibody medication used for the treatment of hemophagocytic lymphohistiocytosis (HLH), which has no cure.
The most common side effects include infections, hypertension, infusion-related reactions, and pyrexia.
The U.S. Food and Drug Administration (FDA) considers it to be a first-in-class medication.[7&a...
* May have multiple approval dates, manufacturers, or labelers.